The immunopharmacology of skin inflammation: The future is already here!

British Journal of Dermatology

Volumn 143, Issue 1, 2000, Pages 47-52

  Greaves, M W ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DERMATOLOGY; FORECASTING; GENE THERAPY; HISTORY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; SKIN DISEASE;

DERMATOLOGY; FORECASTING; GENE THERAPY; HISTORY, 20TH CENTURY; HUMANS; IMMUNOTHERAPY; SKIN DISEASES;

EID: 0034218671     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03588.x     Document Type: Article

References (35)

1. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sei 1998: 94: 557-72.
2. Vayssiere BM, Dupont S. Choquart A. et al Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo. Mol Endocrinol 1997: 11: 1245-55.
3. Corne J, Djukanovic R, Thomas L et al. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety and pharmacokinetics. J Clin Invest 1997; 99: 879-87.
4. MacGlashan DW Jr. Bockner BS. Adelman DC et al. Down regulation of FceRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997; 158: 1438-45.
5. Fahy JV, Boushey HA. Targeting IgE with monoclonal antibodies. The future is now. Clin Exp Allergy 1998: 28: 664-7.
6. Borish LC. Phase I/phase II study of interleukin 4 receptor (IL-4R) in moderate asthma. J Allergy Clin Immunol 1998: 101: 8 (Abstr.).
7. Hide M. Francis DM, Grattan CGEI et al. Autoantibodies against the high affinity IgE receptor as a cause for histamine release in chronic urticaria. N Engl J Med 1993: 328: 1599-604.
8. Niimi N. Francis DM. Kermani F et al Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996; 106: 1001-66.
9. Grattan CEH. Francis DM, Slater NGP et ni Plasmapheresis for severe unremitting chronic urticaria. Lancet 1992: 39: 1078-80.
10. O'Donnell BF, Barr RM, Black A et al. Intravenous immunoglobulin in chronic autoimmune urticaria. Br J Dermatol 1998: 138: 101-6.
11. Raz E, Tighe H. Soato YY et al. Preferential induction of a Thl immune response and inhibition of specific IgE antibody formation by plasmid DNA immunisation. Prof Natl Acad Sei USA 1996; 93: 5141-5.
12. Hanifm JM. Chan SC, Cheng JB et al. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 1996: 107: 51-6.
13. Costello PS, Turner M. Walter AE et al. Critical role for the tyrosine kinase SyK signalling through the high affinity IgE receptor of mast cells. Oncogene 1996; 13: 2595-605.
14. Yousefi S, Hoessli D, Blaser K et al Requirement of Lyn and SyK tyrosine kinases for prevention of apoptosis by the cytokines in human eosinophils. J Exp Med 1996; 183: 1407-14.
15. Mountz JD. Wu J, Cheng J, Zhou T. Autoimmune disease - a problem of defective apoptosis. Arthritis Rheum 1994; 37: 1415-20.
16. Genestier L. Paillot R, Fournel S et al Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 1998; 102: 322-8.
17. Miagkov AV, Kovalenko DV. Brown CE et al. NFκB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sei VSA 1998; 93: 13859-64.
18. Egan RV, Umland SP, Cuss FM, Chapman RV. Biology of interleukin-5 and its relevance to allergic disease. Allergy 1996; 51: 71-81.
19. Howard OMZ, Oppenheim JJ, Wang JM. Chemokines as molecular targets for therapeutic intervention. J din Imimmol 1999; 19: 280-92.
20. Ettehadi P, Greaves MW. Vallach D et al. Elevated tumour necrosis factor (TNF-α) biological activity in psoriatic skin lesions. Clin Exp Immunol 1994: 96: 146-51.
21. Feldman M. Taylor P. Paleolog E et al Anti-TNF-alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. Transplant Proc 1998; 30: 4126-7.
22. Pretolani M, Goldman M. IL-10 a potential therapy for allergic inflammation. Immunol Today 1997; 18: 277-80.
23. Van Devcnter SJ. Elson CO, Fedorak RN. Multiple doses of interleukin-10 in steroid-refractory Crohn's disease. Gastroenterology 1997:113:383-9.
24. Barnes PJ. Nitric oxide and airway disease. Ann Mcd 1995; 27: 389-93.
25. Robert C, Kupper TS. Inflammatory skin diseases, T cells and immune surveillance. N Engl J Med 1999: 341: 1517-828.
26. Pitzalis C, Cauli A, Pipitone N et al Cutaneous lymphocyte antigen-positive T cells preferentially migrate to the skin but not the joint in psoriatic arthritis. Arthritis Rheum 1996; 39: 137-45.
27. Santamaria Babi LF, Picker LJ, Perez Soler MT et al Circulating allergen reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995: 181: 1935-40.
28. Mcdzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila protein signals activation of Troll adaptive immunity. Nature 1997; 388: 394-7.
29. Carlos TM, Harlan JM. Leucocyte-endothelial cell adhesion molecules. Blood 1994; 84: 2068-101.
30. Bennett CF, Condon TP, Chiang MY et al. Inhibition of endothelial cell adhesion molecule expresssion with antisense oligo nucleotides. J Immunol 1994; 152: 3530-40.
31. Abraham WM, Ahmed R, Sabatev JR et al Selectin blockade prevents antigen-influenced late bronchial responses and airways hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med 1999; 159: 1205-14.
32. Kirn MK, Brandley BK, Anderson MB, Bochner BS. Anatagonism of selectin-dependent adhesion of human eosinophils and neutrophils by glycomimetics and oligosaccharide compounds. Am J Respir Cell Mol Biol 1998: 19: 836-41.
33. Cronstein BN. Maled Y, Reibman J et al Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest 1995; 96: 994-1002.
34. Torres CA, Wasaki A, Barber EH, Robinson HL. Differential dependence on target site tissue for gene gun and intramuscular DMA immunization. J Immunol 1997; 158: 4529-32.
35. Anon. Gene therapy under a cloud (Editorial). Lancet 2000: 355: 329.